This disclosure relates to methylsulfonamide derivatives and uses as imaging agents and other uses related to CXCR4 inhibition. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein, derivatives, or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for imaging to study CXCR4 related conditions.
该披露涉及甲基磺酰胺衍
生物及其用途作为成像剂和与CXCR4抑制相关的其他用途。在某些实施例中,该披露涉及包含本文披露的化合物、衍
生物或其药学上可接受的盐或前药的药物组合物。在某些实施例中,本文披露的组合物用于成像以研究与CXCR4相关的疾病情况。